172 related articles for article (PubMed ID: 8944568)
1. Cost effectiveness of detecting Barrett's cancer.
Wright TA; Gray MR; Morris AI; Gilmore IT; Ellis A; Smart HL; Myskow M; Nash J; Donnelly RJ; Kingsnorth AN
Gut; 1996 Oct; 39(4):574-9. PubMed ID: 8944568
[TBL] [Abstract][Full Text] [Related]
2. A surveillance programme for Barrett's oesophagus in a UK general hospital.
Olithselvan A; Gorard DA; McIntyre AS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
[TBL] [Abstract][Full Text] [Related]
3. Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival.
Aldulaimi DM; Cox M; Nwokolo CU; Loft DE
Eur J Gastroenterol Hepatol; 2005 Sep; 17(9):943-50. PubMed ID: 16093872
[TBL] [Abstract][Full Text] [Related]
4. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
[TBL] [Abstract][Full Text] [Related]
5. Screening for Barrett's esophagus.
Zakko L; Lutzke L; Wang KK
Minerva Med; 2017 Feb; 108(1):28-42. PubMed ID: 27792223
[TBL] [Abstract][Full Text] [Related]
6. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus.
Achkar E; Carey W
Am J Gastroenterol; 1988 Mar; 83(3):291-4. PubMed ID: 3125739
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer.
Streitz JM; Ellis FH; Tilden RL; Erickson RV
Am J Gastroenterol; 1998 Jun; 93(6):911-5. PubMed ID: 9647017
[TBL] [Abstract][Full Text] [Related]
8. Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression.
Kastelein F; van Olphen SH; Steyerberg EW; Spaander MC; Bruno MJ;
Gut; 2016 Apr; 65(4):548-54. PubMed ID: 25903690
[TBL] [Abstract][Full Text] [Related]
9. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
[TBL] [Abstract][Full Text] [Related]
10. Cost considerations in implementing a screening and surveillance strategy for Barrett's oesophagus.
Inadomi JM
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):51-63. PubMed ID: 25743456
[TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
12. Barrett's oesophagus: Current controversies.
Amadi C; Gatenby P
World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
[TBL] [Abstract][Full Text] [Related]
13. The rationale for screening and surveillance of Barrett's metaplasia.
Wani S; Sharma P
Best Pract Res Clin Gastroenterol; 2006; 20(5):829-42. PubMed ID: 16997164
[TBL] [Abstract][Full Text] [Related]
14. [Surveillance for Barrett's oesophagus: worthwhile?].
Kastelein F; Kuipers EJ
Ned Tijdschr Geneeskd; 2012; 156(49):A5497. PubMed ID: 23218039
[TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
Provenzale D; Schmitt C; Wong JB
Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
[TBL] [Abstract][Full Text] [Related]
16. Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy.
Rubenstein JH; Inadomi JM; Brill JV; Eisen GM
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):312-8. PubMed ID: 17368230
[TBL] [Abstract][Full Text] [Related]
17. [Detection of early neoplasia in Barrett's oesophagus: focus attention on index endoscopy in short-segment-Barrett's oesophagus with random biopsies].
Behrens A; Pech O; Wuthnow E; Manner H; Pohl J; May A; Ell C
Z Gastroenterol; 2015 Jun; 53(6):568-72. PubMed ID: 26075367
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk in Barrett's oesophagus.
Dias Pereira A; Suspiro A; Chaves P
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
[TBL] [Abstract][Full Text] [Related]
19. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
20. Screening and surveillance of Barrett's esophagus.
Regula J
Dig Dis; 2009; 27(1):54-7. PubMed ID: 19439961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
